Entyvio

Drug Overview
Product Profiles
Entyvio: Crohn's disease
Entyvio: Ulcerative colitis

Figure 6: The authors drug assessment summary of Entyvio in Crohn’s disease
Figure 19: The authors drug assessment summary of Remicade in Crohn’s disease
Figure 5: The authors drug assessment summary of Entyvio in Crohn’s disease
Figure 7: Humira for Crohn’s disease – SWOT analysis
Figure 23: The authors drug assessment summary of Tysabri in Crohn’s disease

Table 1: Entyvio drug profile
Table 2: Entyvio pivotal trial data in Crohn’s disease
Table 3: Entyvio ongoing late-phase trials in Crohn’s disease
Table 14: Entyvio ongoing late-phase trials in Crohn’s disease
Table 5: Entyvio sales for Crohn’s disease across the US, Japan, and five major EU markets, by country, 2016–25
Table 6: Entyvio drug profile